AltMountain

BioPharma Credit PLC

Exeter, United Kingdom · CIK 1702524
Offshore
Status: no Form D since Apr 2017. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

BioPharma Credit PLC is a private investment fund based in Exeter, United Kingdom. According to its most recent Form D, filed Apr 10, 2017, it has sold $270,598,450 of interests to 97 investors since its first sale in Mar 2017. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Pablo Legoretta; Jeremy Sillem; Pedro Gonzalez de Cosio.

Total raised
$270,598,450Cumulative sales reported on Form D
Investors
97
First sale
Mar 27, 2017
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Pablo Legoretta; Jeremy Sillem; Pedro Gonzalez de Cosio
Latest Form D
Apr 10, 2017

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌​‌⁠

Questions about BioPharma Credit PLC

What is the minimum investment for BioPharma Credit PLC?

BioPharma Credit PLC's latest Form D, filed Apr 10, 2017, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in BioPharma Credit PLC?

BioPharma Credit PLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has BioPharma Credit PLC raised?

BioPharma Credit PLC reports $270,598,450 sold from 97 investors on its Form D filed Apr 10, 2017. This is cumulative sales since the offering began, not current assets or performance.

Where is BioPharma Credit PLC based?

BioPharma Credit PLC is based in Exeter, United Kingdom.

When did BioPharma Credit PLC launch?

BioPharma Credit PLC reports its first sale in Mar 2017.

Size compared with every private investment fund

Raised more than 77% of the 111 private investment funds based in United Kingdom, and more than 82% of all 10,333 that report sales.

Similar-size private investment funds in United Kingdom

All private investment funds in United Kingdom